ResMed Inc.
RMDLast close · Oct 16, 2026238.97−3.26 (−1.35%)
Market cap$33.6B
Of the 85 managers this site tracks, 2 held ResMed (RMD) at the end of Q2 2026, their latest 13Fs. The largest position by value was Francois Rochon's, $75.5M; Bridgewater's ($13.1M) follows. No Schedule 13D or 13G is on file for RMD from the activists and large holders the site follows.
Superinvestors holding RMD
| Manager | Firm | Quarter | Shares | Value |
|---|---|---|---|---|
| Francois Rochon | Giverny Capital Inc. | Q2 2026 | 387,665 | $75.5M |
| Bridgewater | Bridgewater Associates, LP | Q2 2026 | 67,381 | $13.1M |
13D/13G are SEC beneficial-ownership disclosures, triggered only above 5%; a 13F is a quarterly snapshot filed up to 45 days after quarter end. Superinvestor names link to their full portfolios under Investors.